10 studies found for:    Obstetric AND Stanford | Recruiting
Show Display Options
Rank Status Study
1 Recruiting Indomethacin Versus Nifedipine for Preterm Labor Tocolysis
Condition: Obstetric Labor, Premature
Interventions: Drug: Indomethacin;   Drug: Nifedipine
2 Recruiting Effects of Oral Probiotic Supplementation on Group B Strep (GBS) Rectovaginal Colonization in Pregnancy
Conditions: Infection;   Pregnancy
Interventions: Dietary Supplement: Placebo;   Dietary Supplement: Probiotic dietary supplement
3 Unknown  Reading in Preterm and Full-term Children: Neural Basis and Prediction
Conditions: Premature Birth;   Basic Learning Problem in Reading;   Child
Intervention:
4 Recruiting Improving Maternal and Child Health in India: Evaluating Demand and Supply Side Strategies (IMATCHINE)
Conditions: Obstetric Labor Complications;   Post-partum Hemorrhage;   Sepsis;   Pre-eclampsia;   Neonatal Mortality
Interventions: Other: Experimental: Treatment 1;   Other: Experimental: Treatment 2
5 Recruiting The Effect of Fatigue on the Clinical Performance
Condition: Fatigue
Interventions: Other: Fatigued;   Other: Rested
6 Recruiting Oxytocin Infusions and Blood Loss in Patients Undergoing Elective Cesarean Delivery.
Condition: Postpartum Hemorrhage
Intervention: Drug: Oxytocin Infusion
7 Recruiting Magnesium Sulfate vs Placebo for Placental Abruption
Condition: Abruptio Placentae
Interventions: Drug: Magnesium Sulfate;   Other: Normal Saline
8 Recruiting Carboplatin, Paclitaxel and Gemcitabine With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
Conditions: Brenner Tumor;   Fallopian Tube Cancer;   Ovarian Clear Cell Cystadenocarcinoma;   Ovarian Endometrioid Adenocarcinoma;   Ovarian Mixed Epithelial Carcinoma;   Ovarian Mucinous Cystadenocarcinoma;   Ovarian Serous Cystadenocarcinoma;   Ovarian Undifferentiated Adenocarcinoma;   Primary Peritoneal Cavity Cancer;   Recurrent Ovarian Epithelial Cancer
Interventions: Drug: paclitaxel;   Drug: docetaxel;   Drug: carboplatin;   Biological: bevacizumab;   Drug: gemcitabine hydrochloride;   Other: laboratory biomarker analysis;   Other: quality-of-life assessment
9 Recruiting Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer
Conditions: Endometrial Clear Cell Carcinoma;   Endometrial Papillary Serous Carcinoma;   Stage I Endometrial Carcinoma;   Stage II Endometrial Carcinoma;   Stage III Endometrial Carcinoma;   Stage IV Endometrial Carcinoma
Interventions: Drug: cisplatin;   Drug: paclitaxel;   Drug: carboplatin;   Radiation: brachytherapy
10 Recruiting Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritorium Cavity Cancer
Conditions: Ovarian Carcinosarcoma;   Recurrent Ovarian Epithelial Cancer;   Recurrent Primary Peritoneal Cavity Cancer;   Recurrent Uterine Sarcoma;   Stage I Uterine Sarcoma;   Stage IA Ovarian Epithelial Cancer;   Stage IA Primary Peritoneal Cavity Cancer;   Stage IB Ovarian Epithelial Cancer;   Stage IB Primary Peritoneal Cavity Cancer;   Stage IC Ovarian Epithelial Cancer;   Stage IC Primary Peritoneal Cavity Cancer;   Stage II Uterine Sarcoma;   Stage IIA Ovarian Epithelial Cancer;   Stage IIA Primary Peritoneal Cavity Cancer;   Stage IIB Ovarian Epithelial Cancer;   Stage IIB Primary Peritoneal Cavity Cancer;   Stage IIC Ovarian Epithelial Cancer;   Stage IIC Primary Peritoneal Cavity Cancer;   Stage III Uterine Sarcoma;   Stage IIIA Ovarian Epithelial Cancer;   Stage IIIA Primary Peritoneal Cavity Cancer;   Stage IIIB Ovarian Epithelial Cancer;   Stage IIIB Primary Peritoneal Cavity Cancer;   Stage IIIC Ovarian Epithelial Cancer;   Stage IIIC Primary Peritoneal Cavity Cancer;   Stage IV Ovarian Epithelial Cancer;   Stage IV Primary Peritoneal Cavity Cancer;   Stage IV Uterine Sarcoma;   Uterine Carcinosarcoma
Interventions: Drug: paclitaxel;   Drug: carboplatin;   Drug: ifosfamide

Indicates status has not been verified in more than two years